The technological challenges are perfectly aligned with BIOLAN HEALTH’s strategy and with BIOLAN’s know-how in the biotechnology, electrochemistry and electronics fields, These three disciplinesallow us to develop our own applications based on enzymatic biosensors and lateral flow immunoassays.
BIOLAN HEALTH also has the capacity granted by the Spanish Agency of Medicines and Health Products (AEMPS), through the previous sanitary license of operation, to carry out the manufacturing activity of medical devices such as Point of Care devices for in vitro diagnosis of different parameters in biological fluids.
All areas of the company are subjected to an evaluation system based on monitoring, auditing and certification.
As a guarantee of our commitment, the company is certified according to the ISO 13485: 2016 Directive 98/79/EC on medical devices for in vitro diagnostics and CE marking for our products.
To achieve this goal, BIOLAN HEALTH manages technologies such as biotechnology, microfluidics, microelectronics and new materials to address the development of a new generation of in vitro diagnostic devices based on two technologies that have proven to be very effective for easy detection, fast, non-invasive and economical for a large number of biological markers for the medical sector:
Collaboration between research companies and healthcare systems is essential in order to facilitate technology transfer through healthcare products and health services to the population.
Bridging the gap between research results and patient care undoubtedly contributes to the improvement of people’s health.
In pursuit of this goal, BIOLAN HEALTH maintains a collaborative work spirit, in its desire to incorporate important organisations, institutions and pharmaceutical and biotechnology companies into its partnership network.
The management of BIOLAN HEALTH is committed to responsible management of the company, in such a way that, being at the forefront of innovation, it could become an international benchmark in its sector. These activities are carried out within an organisational system in which the ethical principles of the company’s social responsibility take precedence: